Imatinib mesylate causes hypopigmentation in the skin.
Leong
Kin Wah
KW
Lee
Thoong Chow
TC
Goh
Ai Sim
AS
D001549:Benzamides; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced* / Q000503:physiopathology; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D020929:Mitogen-Activated Protein Kinase Kinases / Q000494:pharmacology; D010766:Phosphorylation; D010879:Piperazines / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects*
D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D020929:Mitogen-Activated Protein Kinase Kinases